Thermo Fisher Scientific Completes Sale of Genevac


WALTHAM, Mass., April 3: Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has completed the sale of its Genevac business, a manufacturer of vacuum concentrators, to private equity firm Riverlake Equity Partners, LP. Riverlake intends to eventually merge Genevac into its laboratory equipment products and services company, SP Industries, Inc.

On November 9, 2006, Thermo Electron Corporation merged with Fisher Scientific International Inc. to form Thermo Fisher Scientific. The European Commission (EC) and the Federal Trade Commission (FTC) required the divestiture of Genevac, a $17 million business of Fisher Scientific, as the sole condition to their approval of the merger. Under the terms of the FTC Decision and Order, and the Commitments to the European Commission, Thermo Fisher Scientific was required to divest the business to a buyer approved by the FTC and EC by April 9, 2007.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE:TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.

Source: Thermo Fisher Scientific Inc.

CONTACT: Media, Lori Gorski, +1-781-622-1242, lori.gorski@thermofisher.com; Investors, Ken Apicerno, +1-781-622-1111, ken.apicerno@thermofisher.com
Web site: www.thermofisher.com/
Company News On-Call: http://prnewswire.com/comp/877850.html

All Topics